Reactivity of contact allergenic haptens to amino acid residues in a model carrier peptide, and characterization of formed peptide-hapten adducts

Skin Pharmacology and Applied Skin Physiology

Volumn 16, Issue 1, 2003, Pages 59-68

  Ahlfors, S R ^a   Sterner, O ^b   Hansson, Christer ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

Allergic contact dermatitis; Amino acid adduct; Antigen; Benzoquinone; Carrier protein; Cysteine; Hapten; Lysine; Quinone

Indexed keywords

AMINO ACID; COLLAGEN TYPE 4; CYSTEINE; HAPTEN; PEPTIDE;

ALLERGY; ANTIBODY PRODUCTION; ARTICLE; BIOMIMETICS; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; STEREOSPECIFICITY;

AMINO ACIDS; BENZOQUINONES; CARRIER PROTEINS; DERMATITIS, ALLERGIC CONTACT; HAPTENS; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MODELS, CHEMICAL; OLIGOPEPTIDES;

EID: 0037265581     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068288     Document Type: Article

References (29)

1. Belsito DV: The diagnostic evaluation, treatment and prevention of allergic contact dermatitis in the new millennium. J Allergy Clin Immunol 2000;105:409-420.
2. Engelhard VH: How cells process antigens. Sci Am 1994;8:44-51.
3. Lepoittevin JP, Basketter DA, Goossens A, Karlberg AT (eds): Allergic Contact Dermatitis; the Molecular Basis. Berlin, Springer, 1998.
4. Basketter DA, Liden C: Further investigation of the prohapten concept: Reactions to benzene derivatives in man. Contact Dermatitis 1992;27:90-97.
5. Thörneby-Andersson K, Sterner O, Hansson C: Tyrosinase-mediated formation of a reactive quinone from the depigmenting agents, 4-tert-butylphenol and 4-tert-butylcatechol. Pigment Cell Res 2000;13:33-38.
6. Weltzien HU: How T cells recognize haptens. Am J Contact Dermatitis 1995;6:176-180.
7. Lindh CH, Jönsson BA: Human hemoglobin adducts following exposure to hexahydrophtalic anhydride and methylhexahydrophtalic anhydride. Toxicol Appl Pharmacol 1998;153:152-160 (DOI:10.1006/taap.1998.8540).
8. Estlander T, Kostianen M, Jolanski R, Kanerva L: Active sensitization and occupational allergic contact dermatitis caused by para-tertiarybutylcatechol. Contact Dermatitis 1998;38:96-100.
9. Teuber HJ, Staiger G: Reaktionen mit Nitrosodisulfonat VIII Mitteil. Chem Ber 1955;88:802-827.
10. Dupuis G, Mitchell JC, Towers GHN: Reaction of alantolactone, an allergenic sesquiterpene lactone, with some amino acids. Resultant loss of immunologic reactivity. Can J Biochem 1974;52:575-581.
11. Henriot S, Lepoittevin J-P, Trifilieff E: Haptenization of ovalbumin with the skin sensitizer methyl octanesulfonate: Characterization of the methylated OVA323-339 T-cell epitope at His331. J Pept Sci 2001;7:331-337.
12. 13C]hexane-1,3-sultones to human serum albumin. Chem Res Toxicol 2001;14:118-126.
13. Kutyrev AA, Moskva VV: Nucleophilic reactions of quinones. Russ Chem Rev 1991;60:72-88.
14. Boatman RJ, English JC, Pery LG, Fiorica LA: Covalent protein adducts of hydroquinone in tissues from rats: Quantitation of sulfhydryl-bound forms following single gavage or intraperitoneal administration or repetitive gavage administration. Chem Res Toxicol 2000;13:861-872.
15. Cooksey CJ, Land EJ, Rushton FAP, Ramsden CA, Riley PA: Tyrosinase-mediated cytotoxicity of 4-substituted phenols: Use of QSAR to forecast reactivities of thiols towards the derived o-quinones. Quant Struct-Act Relat 1996;15:498-503.
16. Hanzlik RP, Harriman SP, Frauenhoff MM: Covalent binding of benzoquinone to reduced ribonuclease. Adduct structure and stoichiometry. Chem Res Toxicol 1994;7:177-184.
17. Hill BA, Kleiner HE, Ryan EA, Dulik DM, Monks TJ, Lau SS: Identification of multi-S-substituted conjugates of hydroquinone by HPLC-coulometric electrode array analysis and mass spectroscopy. Chem Res Toxicol 1993;6:459-469.
18. Liberato DJ, Byers VS, Dennick RG, Castagnoli N Jr: Regiospecific attack of nitrogen and sulphur nucleophiles on quinones derived from poison oak/ivy catechols (urushiols) and analogues as models for urushiol-protein conjugate formation. J Med Chem 1981;24:28-33.
19. Mason DE, Liebler DC: Characterization of benzoquinone-peptide adducts by electrospray mass spectrometry. Chem Res Toxicol 2000;13:976-982.
20. Rombach EM, Hanzlik RP: Detection of benzoquinone adducts to rat liver protein sulfhydryl groups using specific antibodies. Chem Res Toxicol 1997;10:1407-1411.
21. Carstam R, Hansson C, Lindbladh C, Rorsman H, Rosengren E: Dopaquinone addition products in cultured human melanoma cells. Acta Derm Venereol 1987;67:100-105.
22. Hansson C, Ezzelarab M, Sterner O: Oxidative activation of the propolis hapten Isoprenyl caffeate. Acta Derm Venereol 1995;75:34-36.
23. Monks TJ, Lau SS: Biological reactivity of polyphenolic-glutathione conjugates. Chem Res Toxicol 1997;10:1296-1313.
24. Alt C, Eyer P: Ring addition of the α-amino group of glutathione increases the reactivity of benzoquinone thio ethers. Chem Res Toxicol 1998;11:1223-1233.
25. Schmidt TJ, Lyss B, Pahl HL, Merfort I: Helenanolide type sesquiterpene lactones. 5. The role of glutathione addition under physiological conditions. Bioorg Med Chem 1999;7:2849-2855.
26. Wütrich K: NMR of Proteins and Nucleic Acids. New York, Wiley, 1986, p 17.
27. Agrup G, Hansson C, Rorsman H, Rosengren E: The effect of cysteine on oxidation of tyrosine, dopa, and cysteinyldopas. Arch Dermatol Res 1982;272:103-115.
28. Lau SS, Hill AB, Highet RJ, Monks TJ: Sequential oxidation and glutathione addition to 1,4-benzoquinone: Correlation of toxicity with increased glutathione substitution. Mol Pharmacol 1988;34:829-836.
29. Schmidt RJ, Khan L, Chung LY: Are free radicals and not quinones the haptenic species derived from urushiols and other contact allergenic mono- and dihydric alkylbenzenes? The significance of NADH, glutathione, and redox cycling in the skin. Arch Dermatol Res 1990;282:56-64.